Find information on thousands of medical conditions and prescription drugs.

Cefaclor

Cefaclor (brand names Ceclor®, Raniclor®) is a 2nd generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

A

B

C

Calcium folinate

Chenodeoxycholic acid

Chloramphenicol

Chlordiazepoxide

Chlorprothixene

Chlortetracycline

Choriogonadotropin alfa

Chorionic gonadotropin

Clavulanic acid

Cyclobenzaprine

Cyclophosphamide

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Cefaclor: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References $39.36			ACS Dobfar visit parallels Biochimica cefaclor audit.(deficiencies found in production of pharmaceutical ingredient) : An article from: Inspection Monitor $5.95

		Cefaclor: into the Next Decade $15.55


	Treatment of B-hemolytic streptococcal pharyngitis with cefaclor or penicillin: efficacy and interaction with beta-lactamase-producing organisms in the Pharyngitis, or inflammation of the mucous membranes and underlying areas of the throat, can be caused by bacteria infection of group A beta-hemolytic streptococcus (GABHS). One effective treatment fo From Journal of Family Practice, 2/1/91 by Barbara D. Reed

	Ivax to market extended-release cefaclor - Brief Article Ivax Corp. gained FDA approval to market cefaclor extended-release tablets 500 mg. Cefaclor extended-release tablets are indicated for the treatment of mild-to-moderate infections caused by suscepti From Drug Store News, 2/19/01

	A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults - chronic obstructive pulmonary disease In this multicenter, observer-blinded study, 301 patients with signs and symptoms of acute bacterial exacerbation of COPD were randomized (2:1) to receive ... From CHEST, 11/1/93 by Harry Phillips

	Foreign drug firm pleads guilty to felony charges - Investigator's Reports - Roussel Uclaf S.A. pleads guilty to fraud on behalf of Biochimica Opos S.p.A A French pharmaceutical company has been fined $33 million for deliberately failing to disclose to Food and Drug Administration officials all of the ... From FDA Consumer, 1/1/02 by Carol Lewis

	Update on treating uncomplicated skin and skin structure infections Abstract Dermatologists treat a variety of uncomplicated skin and skin structure infections (uSSSIs) such as folliculitis, impetigo, erysipelas, cellulitis, ... From Journal of Drugs in Dermatology, 11/1/05 by Theodore Rosen

	Community prescribing and resistant Streptococcus pneumoniae We investigated the association between prescribing antimicrobial agents and antimicrobial resistance of Streptococcus pneumoniae among children with ... From Emerging Infectious Diseases, 6/1/05 by Galia Barkai

	Evaluation of poststreptococcal illness Group A beta-hemolytic streptococcal pharyngitis, scarlet fever, and rarely asymptomatic carrier states are associated with a number of poststreptococcal ... From American Family Physician, 5/15/05 by Ricardo G. Hahn

	Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy school children in Turkey Background & objectives: Information on oropharyngcal carriage rates of Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes and Moraxella ... From Indian Journal of Medical Research, 11/1/04 by Gazi, Hörü

Home

Contact

Resources

ebay